Innovative and diverse
industry approach
The Naissos Group (TNG) is an entrepreneurial, family-owned private investment firm that launches its own innovative ventures and at the same time invests in and partners with companies across an array of industries, with a strong focus in the life sciences. TNG was founded in 2008, and today manages a diversified portfolio of investments that includes wholly-owned companies, stealth-mode ventures, and minority positions in outside investments.
Our philosophy
It's simple.
We are entrepreneurs at heart: constantly brainstorming, ideating, and thinking about the next venture that might eventually rock the status quo. One left-brained (Alex), the other right-brained (Mika), our partners don’t always see eye to eye, but when they do, it’s usually the birth of another investment or entrepreneurial venture.
It's lean.
Whether outcompeting established strategy consulting firms with a lean engagement model in which a senior, multidisciplinary team takes an active role, or investing in fine art from a region that receives little attention, we strive to identify unique ways of making an impact and doing things differently.
It's personal.
Most importantly, we aren’t passive investors. When we are a true believers, we roll up our sleeves and become actively involved in the day-to-day management of, or we have a significant advisory role in the ongoing operation of each portfolio company. We want our partners and employees to know that we have a vested interest in each company.
A believer's philosophy.
While Alex maintains an organized workbook of Mika’s ideas for ventures that could solve a problem or address an unrecognized need, this awkward duo retains a certain optimism that one day they will find the bandwidth and resources to further develop at least some of their wild ideas.
The TNG
family of companies
The TNG portfolio
Enterin joined our portfolio in 2016. This biotech was developing innovative approaches to understanding the gut-brain axis and its role in neurodegenerative disease. Over several years, we supported Enterin with a range of commercial, communications, and clinical operations services.
Oncolyze joined our portfolio in 2019. We built a strong interest in the oncology therapeutics behind this innovative biotech, taking an equity position and committing to operations and strategic communications. We are actively collaborating with Oncolyze as it advances its approach to cancer treatment.
Prolocor joined our portfolio in 2020 just months after being founded by two experienced cardiologists. We are actively collaborating with Prolocor as it builds a company to develop and commercialize an exciting precision medicine diagnostic for assessing cardiovascular risk.
AvanzaRx joined our portfolio in 2021. We collaborated with this biotech as it developed therapeutics to modulate novel or previously unreachable immunological targets for the treatment of inflammatory and fibrotic diseases, initially of the lungs.
Our Team
alex stojanovic, phd
managing partner
Over the past 20+ years, Alex has worked or consulted for more than 60 companies, lived on 3 continents, and conducted business in more than 20 countries. Alex specializes in commercial strategy throughout the product lifecycle, portfolio planning + scenario analysis, business development / M+A and investor relations.
Alex is a Co-Founder + CEO at Qoolo. He also co-manages TNG Creative and Naissos Art, while leading all operations for the group.
Alex holds a PhD in Pharmacology from Dartmouth College and he completed a postdoctoral fellowship at Northwestern University.
mika stojanovic, mba
managing partner
For more than 15 years, Mika has been instrumental in growing TNG Creative, our first portfolio company. Under her leadership, it has become an award-winning communications agency with clients across North America, Europe, Asia, and Australia.
Mika is a Co-Founder + Chief Marketing Officer at Qoolo. She also co-manages TNG Creative and Naissos Art, while leading all marketing efforts for the group.
Mika holds a Global Executive MBA from INSEAD, during which she studied in Europe, Asia, and North America. Mika has also completed executive education at Columbia University.
Get in touch
Thank you for visiting our website.
We are passionate entrepreneurs + investors, and we enjoy working with a diverse group of like-minded entrepreneurs, startup teams, and small to mid-sized life-science companies, as well as life-science focused investors, venture capital and private equity firms.
We are located in Princeton NJ, but our portfolio companies, collaborators, and network are global. No matter where you are located, if you think there are synergies or opportunities to work together, reach out.
All rights reserved.